Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Wearing a hijab may lead to earlier hair loss due to vitamin D deficiency and scalp conditions.

Scarring alopecia causes permanent hair loss, and treatment aims to reduce inflammation and stop it from getting worse.

A new treatment using hydroxychloroquine, hyaluronidase, and steroids may improve hair loss from dermal filler complications.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

Coconut oil beads may help treat hair loss in black women.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Treatment improved some symptoms but not all.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Tinea can cause scarring alopecia in children, and fungal culture is crucial for diagnosis.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Alternative treatments with nutrients, minerals, and vitamins are being explored for safer hair loss management.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.